Synapse

← Deepak L. Bhatt

Papers by Deepak L. Bhatt

Page 8 · newest first

  1. Endpoint adjudication in cardiovascular clinical trialsEuropean Heart Journal · 2023
  2. Effectiveness of icosapent ethyl on first and total cardiovascular events in patients with metabolic syndrome, but without diabetes: REDUCE-IT MetSynEuropean Heart Journal Open · 2023
  3. Eicosapentaenoic acid, arachidonic acid, and triglyceride levels mediate most of the benefit of icosapent ethyl in REDUCE-ITEuropean Heart Journal · 2023
  4. Efficacy of Sotagliflozin in Adults With Type 2 Diabetes in Relation to Baseline Hemoglobin A1cJournal of the American College of Cardiology · 2023
  5. Icosapent ethyl for hypertriglyceridaemia and atherosclerosis: greater RESPECT for increased therapeutic useEuropean Heart Journal · 2023
  6. Personalized Medicine for Cardiovascular Disease Risk in Artificial Intelligence Framework2023
  7. Changes in physical activity and incident cardiovascular events in cancer survivorsEuropean Heart Journal · 2023
  8. Artificial Intelligence, Computational Simulations, and Extended Reality in Cardiovascular InterventionsJACC: Cardiovascular Interventions · 2023
  9. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristicsAmerican Heart Journal · 2023
  10. Higher Procedural Volumes Are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute Ischemic StrokeAnnals of Neurology · 2023
  11. Pre-arterialization of coronary veins prior to retroperfusion of ischemic myocardium: percutaneous closure deviceFrontiers in Cardiovascular Medicine · 2023
  12. Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular DiseaseJAMA Network Open · 2023
  13. Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES TrialJournal of the American Heart Association · 2023
  14. Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping ReviewClinical Therapeutics · 2023
  15. Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk FactorsJournal of the American College of Cardiology · 2023
  16. Heart failure medical therapy prior to mitral transcatheter edge-to-edge repair: the STS/ACC Transcatheter Valve Therapy RegistryEuropean Heart Journal · 2023
  17. Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future DirectionsJournal of Clinical Medicine · 2023
  18. Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 TestsCirculation · 2023
  19. Baseline Characteristics of Patients Enrolled in the EMPACT-MI TrialEuropean Journal of Heart Failure · 2023
  20. Pleiotropic Effects of Influenza VaccinationVaccines · 2023
  21. Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-AnalysisCirculation Cardiovascular Interventions · 2023
  22. Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 DiabetesDiabetes Care · 2023
  23. Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based studyScientific Reports · 2023
  24. Quantitative imaging biomarkers of coronary plaque morphology: insights from EVAPORATEFrontiers in Cardiovascular Medicine · 2023
  25. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related EventsJACC Heart Failure · 2023
  26. Cardiovascular Effects of GnRH Antagonists Compared With Agonists in Prostate CancerJACC CardioOncology · 2023
  27. Early versus delayed coronary angiography in patients with out-of-hospital cardiac arrest and no ST-segment elevation: a systematic review and meta-analysis of randomized controlled trialsClinical Research in Cardiology · 2023
  28. GRACE scores or high-sensitivity troponin for timing of coronary angiography in non-ST-elevation acute coronary syndromesClinical Research in Cardiology · 2023
  29. Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-UpCirculation · 2023
  30. Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseaseEuropean Journal of Preventive Cardiology · 2023
  31. Low-Density Lipoprotein Cholesterol Levels in Adults With Coronary Artery Disease in the US, January 2015 to March 2020JAMA · 2023
  32. Development and validation of a predictive model for the diagnosis of rheumatic heart disease in low-income countries based on two cross-sectional studiesInternational Journal of Cardiology Cardiovascular Risk and Prevention · 2023
  33. Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community SurveillanceJournal of the American Heart Association · 2023
  34. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASHNew England Journal of Medicine · 2023
  35. The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trialNature Medicine · 2023
  36. An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized controlled trials2023
  37. Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic StrokeJAMA · 2023
  38. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research ConsortiumCirculation · 2023
  39. Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcomeAmerican Journal of Preventive Cardiology · 2023
  40. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registryClinical Research in Cardiology · 2023
  41. Assessment of Atherothrombotic Risk in Patients With Type 2 Diabetes MellitusJournal of the American College of Cardiology · 2023
  42. Smoking habit change after cancer diagnosis: effect on cardiovascular riskEuropean Heart Journal · 2023
  43. Transcatheter Mitral Valve Repair for Degenerative Mitral RegurgitationJAMA · 2023
  44. Mortality trends of aortic stenosis in high-income countries from 2000 to 2020Heart · 2023
  45. Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic StrokeCirculation · 2023
  46. Impact of Diabetes on Outcomes in Patients Hospitalized With Acute Myocardial Infarction: Insights From the Atherosclerosis Risk in Communities Study Community SurveillanceJournal of the American Heart Association · 2023
  47. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort StudyCirculation · 2023
  48. New approaches to reduce recurrent PCI: to angioplasty and beyond!European Heart Journal Open · 2023
  49. Benefit of icosapent ethyl on coronary physiology assessed by computed tomography angiography fractional flow reserve: EVAPORATE-FFRCTEuropean Heart Journal - Cardiovascular Imaging · 2023
  50. Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohortEuropean Journal of Preventive Cardiology · 2023